US Stock MarketDetailed Quotes

AKBA Akebia Therapeutics

  • 1.3100
  • +0.0500+3.97%
Close Jul 15 16:00 ET
  • 1.3295
  • +0.0195+1.49%
Post 19:55 ET
274.57MMarket Cap-5954P/E (TTM)

About Akebia Therapeutics Company

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.

Company Profile

Company NameAkebia Therapeutics
Listing DateMar 20, 2014
Issue Price17.00
CEOMr. John P. Butler
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address245 First Street,Suite 1400
CountryUnited States of America
Zip Code02142

Company Executives

  • Name
  • Position
  • Salary
  • John P. Butler
  • Director, President and Chief Executive Officer
  • 2.78M
  • Richard C. Malabre
  • Chief Accounting Officer
  • --
  • Erik John Ostrowski
  • Senior Vice President, Chief Financial Officer, Chief Business Officer and Treasurer
  • --
  • Nicholas Grund
  • Senior Vice President and Chief Commercial Officer
  • --
  • Dr. Steven Keith Burke, M.D.
  • Senior Vice President, Research and Development and Chief Medical Officer
  • 1.21M
  • Adrian Adams
  • Chairman of the Board
  • 171.63K
  • Ronald E. Frieson
  • Independent Director
  • 147.97K
  • Cynthia Smith
  • Independent Director
  • 151.50K
  • LeAnne M. Zumwalt
  • Independent Director
  • 143.31K
  • Dr. Steven C. Gilman, PhD
  • Independent Director
  • 139.87K
  • Michael W. Rogers
  • Independent Director
  • 145.79K
  • Dr. Myles Wolf, M.D.
  • Independent Director
  • 144.43K


Analyst Rating

No Data

Price Target

No Data

Heat List
Latest Price